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Summary
Objective: To investigate involvement of the integrin alpha5 subunit of the classical fibronectin receptor in cartilage chondrolytic activities of
fibronectin fragments (Fn-f).
Design: Bovine chondrocytes and cartilage explants were cultured in the presence of antisense oligonucleotide (ASO), or sense (SO) or
scrambled sequence oligonucleotide (SCO) corresponding to the bovine alpha5 subunit. The effects of the oligonucleotides on mRNA and
protein expression of the alpha5 subunit were analysed by rtPCR and Western blotting, respectively. To test effects on Fn-f activities, three
different Fn-f were first added to serum or serum-free cultures, followed by addition of oligonucleotides and the effects on Fn-f mediated
proteoglycan (PG) degradation, cartilage PG depletion and PG and general protein synthesis suppression were tested.
Results: The ASO decreased alpha5 mRNA and protein expression to 69% and 55%, respectively, in monolayer cultures and decreased
protein expression 67% in cartilage explants, while SO and SCO were ineffective. The ASO partially reversed the ability of the Fn-fs to
suppress PG and general protein synthesis in cartilage explant and high density chondrocyte cultures. Concentrations of ASO from 1 nM to
5 M effectively suppressed Fn-f activities in particular assays and the effects were reversible, while SO and SCO were not significantly
effective. ASO also suppressed, in a dose-dependent and reversible fashion, the ability of the Fn-fs to enhance degradation and release of
PG from cartilage explants. The ASO were also effective in suppressing the ability of an antibody to the alpha5 subunit to enhance PG
degradation, but were ineffective in blocking endotoxin or IL-1 enhanced degradation.
Conclusions: These data implicate the alpha5 integrin subunit in Fn-f mediated activities, consistent with a role for the alpha5beta1 integrin
in this pathway. © 2002 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
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Fibronectin (Fn) is an extracellular matrix protein that is
easily degraded into fragments (Fn-fs) by many different
types of proteinases. In synovial fluids of patients with
osteoarthritis (OA) and rheumatoid arthritis (RA)1–5, levels
of Fn-fs are greatly enhanced. Further, the Fn content and
Fn synthesis rates within the cartilage are elevated both in
human OA cartilage6,7, in a canine surgical model
of cartilage damage8,9 or with altered biomechanical
loads10–12. These conditions ultimately could provide
higher levels of Fn-fs. The high levels of Fn-fs in synovial
fluids or within the cartilage might be predicted to have a
deleterious effect on the knee joint cartilage, since Fn-fs
can up-regulate catabolic cytokines13,14 and matrix metallo-381proteinase (MMP) expression in articular cartilage15–17 and
temporarily suppress synthesis of proteoglycan (PG)18–20.
The result is severe and irreversible cartilage damage
to bovine explants in vitro18,19,21 and to rabbit knee
joint articular cartilage when Fn-fs are intraarticularly
injected22,23.
The Fn-fs appear to exert their action by binding
chondrocytes21 and enhancing release of the catabolic
cytokines, TNF-, IL-1, IL-1 and IL-613,14. The cytokines
are mostly responsible for the subsequent stromelysin-1
(MMP-3) induction and the suppression of PG synthesis
observed14. Several MMPs are up-regulated, including an
aggrecanase activity22,23, all of which collectively cause
cleavage at a classical MMP site as well as an ‘aggreca-
nase site’, a second physiologically relevant cleavage site.
Interestingly, these proteases and cytokines can increase
the Fn-f pool further, since Fn-fs easily can be generated by
addition of MMP-3 or IL-1 to cartilage24. The major charac-
teristics of this model of cartilage damage have been
reviewed25.
We have proposed that the Fn-fs operate through the
Arg-Gly-Asp-Ser dependent alpha5beta1 integrin receptor,
based on observations that antibodies to this receptor
suppress PG synthesis as do Fn-fs (unpublished), and
analog peptides of the Arg-Gly-Asp-Ser integrin-binding
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that addition of Fn-fs to living chondrocytes, followed by
addition of chemical cross-linker, results in cross-linking of
Fn-fs to the alpha5 protein (submitted). Since the cross-
linking studies only could suggest proximity but not active
involvement of this subunit, our objectives here were to
determine whether the Fn-fs mediated their effects through
the alpha5 subunit.ISOLATION OF FN AND FN-FS
Fn was isolated from human plasma by adsorption to
gelatin-Sepharose and elution with 3 M urea15. A well-
characterized amino-terminal heparin-binding 29 kDa Fn-f
and a 50 kDa gelatin-binding Fn-fs were isolated by
sequential cathepsin D and thrombin digestion of Fn as
described15. A mixture of carboxyl-terminal 140 kDa and
smaller Fn-fs not contained in the 29 kDa or 50 kDa Fn-fs
were isolated by cathepsin D digestion as described15 and
were used without further purification. The mixture of
140 kDa and smaller Fn-fs is referred to as the 140 kDa
Fn-f. The three Fn-fs solutions represented the entire
polypeptide chain of Fn. All Fn-f solutions were dialysed
against 20 mM phosphate buffer, pH 7.4, containing
150 mM NaCl, passed through De-toxi Gel from Pierce
Chemical Co. (Rockford, IL) to remove trace endotoxins
and sterile filtered prior to use. Periodic testing for endo-
toxin with the endotoxin kit from Sigma Chemical Co.
typically showed insignificant levels of endotoxin of less
than 50 pg per mg of Fn-f. As an additional verification that
LPS does not play a role in Fn-f mediated activities,
polymixin B sulfate, which inactivates LPS, was added at a
final concentration of 10 g/ml to Fn-f treated cultures in
DMEM. The Fn-f PG degradation rates (determined as
described below) without and with polymixin treatment,
respectively, were 3.95±0.4 and 4.06±0.28 g PG/mg
cartilage/day. Also, polymixin did not alter significantlythe ability of Fn-fs to suppress PG synthesis. Thus, the
activities of the Fn-f solutions could not be due to endotoxin
contamination.EXPLANT CARTILAGE CULTURES
Culturing of articular cartilage slices from adult (18–20
months of age) bovines was performed as described15,18 in
DMEM containing 50 U/ml penicillin/streptomycin with 10%
serum/DMEM with 50–80 mg cartilage in 2 ml of media.
Each datum was a mean and the S.D. values were based on
at least three similar tissue culture wells. For each major
parameter at least three separate harvests were studied,
with a total of over 15 harvests for the collective study.ISOLATION OF CHONDROCYTES FOR MONOLAYER CULTURES
Articular cartilage was removed aseptically from the
metacarpophalangeal joints of 18–20-month-old bovines,
the cartilage tissue was subjected to a 90 min pronase
(Calbiochem, San Diego, CA) digestion followed by an 18 h
collagenase P (Boehringer Mannheim, Indianapolis, IN)
digestion in DMEM/5% FBS as described17. The resulting
cell suspension was washed repeatedly, cell counted and
the cells were plated at 0.75 million cells/well in a 24-well
plate in DMEM/10% FBS. The media were changed every
other day and serum-free cultures were started on day 3
after washing with 8–10 volumes of DMEM.DESIGN OF ANTI-SENSE OLIGOS
Antisense (ASO), sense (SO) and scrambled (SCO)
oligos derived from the sequence of the alpha5 subunit
of the Fn integrin were purchased from Integrated DNA
Technologies, Inc. (Coralville, IA). The phosphorthioate
analogs, which penetrate cell membranes better, have an
increased affinity for the target and have slower rates of
degradation by nucleases, were utilized. The antisense
sequence was derived from the coding sequence (bases
121–144) of the bovine alpha5 subunit (Accession #
U10866)27. The ASO sequence was 5′-CTCTGCCTCGTA
GGCGCCACCCTC-3′. The negative control SO sequence
was homologous to the mRNA sequence: 5′-GAGGG
TGGCGCCTACGAGGCAGAG-3′. The negative control
SCO sequence had the same G:C content as the antisense
sequence. The scrambled sequence, GAGGTGCGGCG
CCAGAACGTGCAG, was not predicted to bind to any
known sequence (by Blast analysis). All sequences were
checked with the EMBO database for uniqueness and all
oligos were HPLC-purified.ANALYSIS OF ALPHA5 MRNA
Chondrocytes from bovine articular cartilage treated with
different parameters were grown in monolayers and then
lysed directly in a culture dish by use of Trizol Reagent as
described by the supplier (Life Technologies, Grand Island,
NY). This protocol involves Trizol/chloroform treatment,
followed by isopropyl alcohol precipitation and ethanol
washes of the resultant pellet. GeneAmp RNA PCR kit
components (Perkin Elmer, Foster City, CA) were used to
reverse transcribe the isolated RNA to cDNA, according to
the manufacturer’s protocol. Each sample solution for
reverse transcription contained 5 mM MgCl2 1×PCR
Buffer, 1 mM of each dNTP, 1 U/l RNase Inhibitor, 2.5 U/l
Murine Leukemia Virus Reverse Transcriptase, 0.75 MMaterials and methods
Except where noted, all common chemical reagents and
chromatography resins were from Sigma Chemical Co. (St
Louis, MO). Dulbecco’s modified Eagle’s medium (DMEM)
and penicillin-streptomycin were from Sigma Chemical
Co. The Enhanced Chemiluminescent (ECL) kit used for
Western blot detection was the Super Signal Chemilumi-
nescent Substrate kit for HRP from Pierce Chemical
Co. (Rockford, IL). [35S] sulfate (43 Ci/mg S) and
[35S] methionine/cysteine (1000 Ci/ml) were from ICN
Biomedicals Inc. (Cosa Mesa, CA). Oligonucelotides (oli-
gos) were purchased from Integrated DNA Technologies,
Inc. (Coralville, IA). RNA isolation supplies were from Life
Technologies (Grand Island, NY). Supplies for RT-PCR
were from Perkin Elmer (Foster City, CA). PCR products
were purified using a Wizard PCR prep DNA purification kit
(Promega, Madison, WI). cDNA was sequenced by
Sequetech Corporation (Mountain View, CA). Polyclonal
affinity purified rabbit antibody to integrin alpha5 (CDw49e)(with cross-reactivity to human, bovine, chicken, rat and
mouse) was from Chemicon International Inc. (Temecula,
CA). E coli LPS (026-B6) and polymixin B sulfate were
from Sigma Chemical Co. (St Louis, MO). Mouse anti-
human integrin alpha5beta1 monoclonal antibody (cat#
MAB1969) was from Chemicon International Inc.
(Temecula, CA). Recombinant human IL-1 was from R&D
Systems (Minneapolis, MN).
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AGT CCT G-3′), 0.5 g test RNA and DEPC treated deion-
ized water for a final volume of 20 l. The sample tubes
were incubated in a Perkin–Elmer thermal cycler at the
following settings: preheat file—95° for 5 min; 5° for 5 min,
reverse transcription file: 42° for 1 h; 95° for 6 min; 5° for
5 min.
The resultant cDNA subsequently was amplified using
AmpliTaq DNA Polymerase. A 20 l reverse transcription
reaction volume was adjusted to the final concentrations
of 2 mM MgCl2, 1×PCR Buffer, 2.5 U/100 l DNA
Polymerase, DEPC treated deionized water, 0.15 M of
upstream primer for alpha5 (5′-AGA AAA CCA TCC AGT
TTG AC-3′) and a final 100 l volume. All solutions were
incubated in a Perkin–Elmer thermal cycler with the follow-
ing settings: polymerase chain reaction file—95° for 2 min
(1 cycle); 95° for 45 s, 60° for 30 s (30 cycles); 72° for 45 s
(1 cycle).
The amplified PCR product was subjected to electro-
phoresis on a 1% agarose gel, the gel stained with ethidium
bromide and visualized using Quantity One software on a
Flour-S Multimager (BioRad Laboratories, Richmond, CA).
After amplifying the PCR product further, the PCR products
were purified using a Wizard PCR prep DNA purification kit
(Promega, Madison, WI). The purified DNA product was
then analysed on an agarose gel to verify purity and the
concentration of the purified DNA determined by reference
to the molecular standards. A solution of purified cDNA,
at about 5 ng/l, was submitted for single primer exten-
sion sequencing, in two directions, using at 15 M the
alpha5 upstream and downstream primers (Sequetech
Corporation, Mountain View, CA).WESTERN BLOTTING AND CHEMILUMINESCENT DETECTION OF
ALPHA5 PROTEIN IN CELL LYSATES
An aliquot of cell lysate of 10 l (typically 1–2 million
cells) was applied to a 7.5% acrylamide SDS gel and the
gel blotted onto nitrocellulose for 18 h at 30 V, followed by
1 h at 90 V. The blot was then treated with 3% BSA in
50 mM phosphate buffer, pH 7.4, containing 150 mM NaCl,for 1 h to block non-specific absorption sites. The blot then
was incubated with 7 g/ml (1 to 300 dilution) of rabbit
antialpha5 antibody for 1 h, followed by six washes with the
phosphate buffer (15 min per wash). The blot was then
reacted with HRP conjugated goat antirabbit IgG (Sigma #
A-0545; 1:40,000 titer by direct ELISA) for 1 h (1:20,000
fold dilution of 1 mg/ml with 0.05% Tween 20, 1% BSA, in
the phosphate buffer). After washing six times with phos-
phate buffer-Tween 20, the blot was reacted with ECL
premixed substrate solution (Pierce Chemical Co.) for
1 min then applied to the membrane. The blot was then
placed in a plastic membrane protector and subjected to
autoradiography for up to 30 s.RATES OF SODIUM 35S-SULFATE AND 35S-METHIONINE/CYSTEINE
INCORPORATION
Sulfate incorporation was used as an index of synthesis
of sulfated PG as described18,19. Briefly, rates were
measured using a 2-h pulse with 10 Ci/ml of 35S-sodium
sulfate in 1.5 ml of 10% serum/DMEM, followed by a 2-h
cold chase with 10% serum/DMEM. Slices were extracted
with 1 ml of 4 M Guanidine HCl, 0.1% Triton X-100, 10 mM
EDTA, 100 mM sodium acetate, pH 5.5, for 16 h at 9°C,
followed by exhaustive dialysis of the extracts against
10 mM EDTA-water, adjusted to pH 5.5. The amount of
label was expressed as dpm/mg wet weight cartilage,
converted into % of control values and means and S.D.
values were reported from 3–6 similar culture wells. For
comparison of experimental data to control data, datasets
were subjected to Dunnet analysis to obtain P values,
where a P value <0.05 was considered significant. Rates of
protein synthesis were measured using 10 Ci/ml 35S-
methionine/cysteine for a two-hour labeling in the same
way as 35S-sulfate incorporation was measured above.Fig. 1. Effect of phosphorthioate oligos on alpha5 mRNA as determined by RT-PCR–chondrocytes from bovine articular cartilage treated with
different parameters were grown in monolayers in the presence or absence of oligonucleotides for 3 days in serum free conditions and then
lysed directly in a culture dish by use of Trizol Reagent. The isolated RNA was reverse transcribed using a GeneAmp RNA PCR kit. The
resultant cDNA subsequently was amplified using AmpliTaq DNA Polymerase and the product subjected to electrophoresis on a 1% agarose
gel at 120 V for 1.5 h and the gel stained with ethidium bromide and visualized using Quantity One software on a Flour-S Multimager (BioRad
Laboratories, Richmond, CA). Each lane represents 50 ng of amplified PCR product. Lanes on left are of GADPDH amplification and on right,
of alpha5. Shown are lanes for SO (sense oligo), ASO (antisense oligo) and SCO (scrambled oligo) treatment. For some lanes, divider lanes
were used to compensate for heavy protein loading and the divider lanes removed to allow merging of the lanes for the final image.RATES OF PG RELEASE INTO MEDIA OF CARTILAGE CULTURES
EXPOSED TO FN-FS
Rates of release of degraded PG from cartilage
explants into the conditioned media were measured as
384 G. A. Homandberg et al.: Antisense blocks fibronectin fragmentsdescribed15,21, using the dimethylmethylene blue (DMB)
dye-binding assay. Briefly, a volume of 0.8 ml DMB
reagent, prepared as described28, was mixed with 190 l of
1.37 M Guanidine HCl and 10 l of test sample and after
2 min, a spectrophotometer was used to determine absorb-
ances at 525 and 595 nm, using water as a blank. The
ratios of 525 nm absorbance over 595 nm absorbance
were used to establish a standard curve with purified PG
and a standard curve of 0.5 to 3 g/ml purified bovine PGused to estimate PG contents in the papain digests. The
PG contents per mg wet weight cartilage for each of three
culture wells per time point were then graphed vs days and
the data subjected to linear regression to obtain slopes and
S.E.M. values. Typically, assays were performed of triplicate
wells per time point at days 1, 3, 5, 7 and 9, resulting in a
15-point curve for linear regression analysis. The slopes
are reported as rates of g PG/mg wet weight cartilage/day.
The regression coefficients were typically greater than
0.90. Rates were compared to the respective controls using
Dunnet analysis to obtain P values.PG-CONTENT OF CARTILAGE
The total amount of g PG/mg wet weight cartilage was
determined by assays with DMB reagent after treatment of
50–80 mg of cartilage in 1.0 ml of 50 mM phosphate buffer,
pH 6, containing 10 mM EDTA and 10 mM cysteine, with
50 g/ml papain for 16 hours at 65°C as described20.TESTS OF OLIGOS
To test effects of oligos on chondrocytes, cells were
plated into 24-well plates in 10% serum/DMEM and after
typically 3 days, the medium was changed to DMEM and
oligos added from a 0.1 mM stock solution in DMEM. After
2 days, the media were changed, fresh oligos added as
well as Fn-fs and assays begun. Three wells were used for
each datum and each experiment was performed at least
three times. Therefore, the means and S.D. values reported
are from at least nine culture wells from at least three
different chondrocyte culture preparations. The 29 kDa Fn-f
was used in all cases at 1 M, while the 50 kDa and
140 kDa Fn-fs were used at 2 and 3 M, respectively. This
was done since the 29 kDa Fn-f is the most active and the
lower activity of the others makes assays of them at 1 M
more error prone. In each experiment, controls of SCO, or
SO or ASO alone were always run, in order to validate
comparisons to experiments of oligos added in combination
with the Fn-fs. Pairwise comparisons of experimental data
to control data were performed by Student’s t-test analysis.
To test effects of oligos on cartilage explants, 1 day after
establishing the culture, the medium was changed to
DMEM and oligos added. After 1–5 days, the medium was
changed, oligos added back with Fn-fs and aliquots of the
media drawn every day for up to 5 days and PG content
determined for each time point. These experiments
were performed with at least three different cartilage
preparations. Therefore, for 5 days per kinetic rate and five
different cartilage preparations, the mean and S.E.M. values
were based on at least 25 points. Oligos were tested on at
least three tissue preparations from separate harvests. As
above, for each experiment a full set of controls with each
Oligo added alone were tested. Statistical analysis was
based on the Student’s t-test.ResultsFig. 2. Effect of 1 M ASO, SO and SCO on alpha5 protein in
explant and monolayer cultures. (a) Bovine explants in DMEM
were cultured with oligos for 3 days, followed by a media change,
re-adjustment to 10 M oligos and adjustment to 1 M 29 kDa
Fn-f. After an additional 2 days, the cartilage was extracted and the
extract then dialysed against 10 mM EDTA and finally concen-
trated 10×. An aliquot was subjected to Western blotting for the
presence of alpha5 protein. Lanes are SCO (scrambled oligo)
control, SO (sense oligo) control, ASO (antisense oligo) control,
29 kDa Fn-f and SCO (SCO+f), 29 kDa Fn-f and SO (SO+f), ASO
and 29 kDa Fn-f (ASO+f). (b) High density bovine chondrocyte
cultures in DMEM were incubated with 1 M oligos for 1 day,
followed by a media change, re-adjustment to 1 M oligos and
adjustment to 1 M 29 kDa Fn-f. After an additional 2 days, the
cells were washed and lysed with octylglucoside and the soluble
component concentrated 10× and subjected to Western blotting
for alpha5 subunit. Lanes are designated as in panel A. The lanes
are derived from the same gel but divider lanes were used to
compensate for heavy protein loading and the divider lanes
removed to allow merging of the lanes for the final image.THE ASO REDUCED MRNA EXPRESSION AND PROTEIN LEVELS OF
THE ALPHA5 SUBUNIT
The effect of the oligos on mRNA levels of the alpha5
subunit was tested first, after a 2-day incubation with 1 M
oligos. This length of incubation later was found to be
Osteoarthritis and Cartilage Vol. 10, No. 5 3850
400
dp
m
/m
g 
ca
rt
il
ag
e
Co
nt
1S
C 1S 1A
S
5S
C 5S 5A
S f2
9
1S
C 
+ 
f2
9
1S
 +
 f2
9
5S
C 
+ 
f2
9
5S
 +
 f2
9
0.0
01
AS
 +
 f2
9
0.0
1A
S 
+ 
f2
9
*
0.1
AS
 +
 f2
9
**
1A
S 
+ 
f2
9
**
5A
S 
+ 
f2
9
**
300
200
100
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in DMEM were treated with oligos for 2 days, followed by change of media to include oligos and 1 M 29 kDa Fn-f. After 48 h after addition
of Fn-f medium was then adjusted to 5 Ci/ml 35S sulfate. After 2 h, the cartilage was recovered, weighed and extracted and the extracts
dialysed exhaustively against water. After scintillation counting, the cpm were expressed as dpm/mg wet weight cartilage. Designations are:
SC for SCO (scrambled oligo); S for SO (sense oligo); AS for ASO (antisense oligo). Numbers in front of oligos refer to M concentrations.
P values of <0.05 or <0.01 are designated as * and **, respectively. Comparisons were made to Fn-f alone as control.maximal for reversing Fn-f activities. Chondrocyte mono-
layer cultures were incubated in DMEM with oligos, the
RNA was isolated and subjected to RT-PCR and the PCR
products analysed by agarose electrophoresis. The results
from three separate gels were averaged. Figure 1 is a
representative gel and shows that the ASO decreased
mRNA levels as compared to SO and SCO. For this
particular cell harvest, ASO significantly decreased mRNA
levels to 31±6% of control SO values (100±14%)
(P=0.001; Student’s t-test) and to 41±8% (P=0.003) of
control SCO values (100±17%) (P=0.012; Student’s
t-test). Two other experiments with different cultures also
showed that ASO decreased mRNA levels to 35±9% and
41±4% relative to ASO levels.
Sequencing results confirmed that the identified PCR
products of both SO and ASO treated chondrocytes were
from the alpha5 gene. Using PC gene software, alignment
between the alpha5 and antisense DNA upstream showed
91.5% homology. Alignment between the alpha5 and
antisense DNA downstream showed 98.7% homology.
Alignment between antisense upstream DNA and down-
stream DNA showed 92.4% homology.
The effect of the oligos on protein levels of the alpha5
subunit in cartilage tissue was tested next. The results
from three separate gels were averaged. Figure 2(a) is arepresentative gel and shows that 1 M ASO effectively
decreased alpha5 protein in explant cultures as compared
with SCO or SO. ASO decreased alpha5 protein levels to
33±9% of control SCO levels (P=0.002; student’s t-test)
and 24±5% (P=0.001; Student’s t-test) of control SO
levels. Combinations of Fn-f with SCO and SO resulted in
similar protein expression as SCO or SO alone. However,
the combination of ASO with Fn-f resulted in alpha5 protein
levels lower than with ASO alone, perhaps due to an
additional effect of the Fn-f on cartilage tissue. The ASO
also decreased levels to 31±6% and 42±9%, as compared
to SCO in two other experiments performed with different
cartilage harvests.
Similar analysis was performed on monolayer cultures.
Figure 2(b) is a representative gel. The statistics were
based on averaging of densities of three different gels. The
analysis showed that the alpha5 protein levels in SCO- and
SO-treated cultures were not significantly different, how-
ever ASO decreased protein levels to 44±4% of SCO
control alone levels (P=0.007) and to 41±11% of SO alone
controls (P=0.005). ASO also decreased protein levels in
the presence of Fn-f (ASO+f) to 37±7% of SO levels
(P=0.002). These significant effects of ASO were observed
in two other experiments with different chondrocyte
harvests.
386 G. A. Homandberg et al.: Antisense blocks fibronectin fragmentsASO WAS ALSO EFFECTIVE IN DECREASING PG SYNTHESIS
SUPPRESSION AND GENERAL PROTEIN SYNTHESIS IN CULTURED
CARTILAGE
The effects of oligos on blocking Fn-f mediated PG
synthesis suppression was tested next in cartilage
explants. Cartilage was incubated with 1 M oligos for
periods of 1, 2 or 5 days, prior to addition of Fn-fs in order
to define the optimal conditions. A 2- or 5-day treatment
with ASO blocked Fn-f mediated PG synthesis suppression
to the same extent, while the effect at 1 day was much less
(data not shown). Therefore, the effects at 2 days and of
varying concentrations of oligos were studied. Figure 3
shows that concentrations of SO, SCO or ASO as high as
5 M, did not alter significantly the rates of PG synthesis as
compared with the control. The addition of the 29 kDa Fn-f
significantly (P<0.01) suppressed PG synthesis to 40% of
the control level, while 1 or 5 M SO and SCO did not
significantly block the action of the 29 kDa Fn-f. However,
addition of ASO at a concentration as low as 10 nM
significantly decreased Fn-f activity (P<0.01). In other
experiments, the ASO was removed from the pre-
incubation when the 29 kDa Fn-f was added, resulting in a
return to 46±9% PG synthesis suppression after 1 day.
This suggested that the effect of the ASO effect could be
reversed within 1 day. This also suggested that the ASO did
not cause irreversible cytotoxic effects.
The ASO was also signficantly effective in reversing PG
synthesis suppression mediated by the 50 kDa and
140 kDa Fn-fs. The 50 kDa and 140 kDa Fn-fs alone,
significantly (P<0.01) suppressed sulfate incorporation by60% and 53%, respectively, while the ASO significantly
(P<0.01) reversed the activities (data not shown). As
shown earlier, the SCO and SO had no statistically signifi-
cant effects alone, nor did they significantly block either
Fn-f when the data were compared to data for the respec-
tive Fn-f alone. Figure 4 shows the effects of oligos on
methionine/cysteine incorporation as a measure of total
protein synthesis. Each of the Fn-fs suppressed protein
synthesis in a statistically significant fashion (P<0.01) by
29–35%. However, the SCO and SO did not significantly
reverse the Fn-f effect, while the ASO did so in each case.ASO DECREASED FN-F MEDIATED PG SYNTHESIS SUPPRESSION IN
MONOLAYER CULTURES
The oligos were tested next at 1 M for their effects on
monolayer cultures after a 48 h pre-incubation time. Figure
5 shows that the 29 kDa, 50 kDa and 140 kDa Fn-fs alone,
decreased sulfate incorporation by 31, 39 and 45%,
respectively, which was statistically significant (P<0.01) in
each case. Figures also shows that SCO or SO alone had
no significant effect on PG synthesis nor did they signifi-
cantly block the action of each Fn-f, when the data were
compared to those for the respective Fn-f. However, as with
monolayer cultures, 1 M ASO significantly (P<0.01)
blocked the activity of each Fn-f.0
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Fig. 4. Effect of oligos on Fn-f mediated protein synthesis suppression in explant cultures. Similar culturing conditions as in Fig. 3, except that
labeling was with 5 Ci/ml 35S methionine/cysteine. Designations are: SC, scrambled; S, sense; AS, antisense oligos.ASO DECREASED THE KINETICS OF PG DEGRADATION IN FN-F
CULTURED CARTILAGE
The effect on the kinetics of PG degradation was tested
next. Cartilage was tested since monolayer cultures lacked
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Fig. 5. Effect of oligos on Fn-f mediated PG synthesis suppression in chondrocyte cultures. High density bovine chondrocyte cultures in
DMEM were incubated with 1 M oligos, followed after 48 h, by adjustment of the same medium to 1 M in each of the three Fn-f. After an
additional 48 h, the medium was then adjusted to 5 Ci/ml 35S sulfate. After 2 h, the cell layer was lysed and the lysates dialysed
exhaustively against water. After scintillation counting, the cpm were expressed as dpm/well. P values of <0.05 or <0.01 are designated
as * and **, respectively. Comparisons were made to Fn-f alone as control.the extensive matrix required for this type of assay. Oligos
were added to cartilage explants in DMEM for 2 days prior
to addition of Fn-f and fresh oligos. Our initial studies
showed that a 1-day pre-incubation with 1 M ASO
decreased the degradation caused by 1 M 29 kDa Fn-f by
82±12 %, while a 2 and a 5 day pre-incubation, caused a
respective 45±6 and 75±19% reduction. Therefore, we
continued to use a 2-day pre-incubation. The effect of
varying concentrations of oligos on the activity of the
29 kDa Fn-f was assayed. Figure 6 shows that the 29 kDa
Fn-f significantly enhanced PG degradation (P<0.01, when
compared with untreated control). Further, SCO and SO,
from 0.1 to 5 M, had no significant effect on PG degrada-
tion when compared with controls (no Fn-f or oligo), nor did
they significantly block the action of the 29 kDa, when
compared to Fn-f alone. ASO over a range of concentration
had no significant activity by itself, but it did significantly
(P<0.01) block Fn-f activity at concentrations as low as
1 nM ASO, while 10 nM ASO blocked over 50% of the Fn-f
activity. A concentration of 1 M was not significantly better
than 0.1 M. In other experiments, a concentration of
0.2 M 29 kDa Fn-f was substituted for the 1 M, resulting
in the same proportional effect of the ASO (data not
shown).
Figure 7 shows that the 50 kDa and 140 Da Fn-fs
enhanced PG degradation rates. The effects were statisti-
cally significant P<0.01). Figure 7 also shows that 1 M
ASO, but not SCO or SO, blocked the PG degradation
caused by the 50 kDa and 140 kDa Fn-fs to a statisticallysignificant degree, when the rates were compared with
those for the respective Fn-f alone. Some of the above
experiments were repeated in the presence of serum,
which reduced the PG degradation rates of the Fn-f by
60±15% but only reduced the Fn-f activity by 21±3%
activity. Thus, while the ASO was effective in serum, the
relative efficiency was decreased two-fold as compared
with serum-free conditions. In other experiments, cartilage
treated with ASO only for days 0–3, followed by removal
and addition of Fn-f, showed a recovery of degradative
activity to 88±4% of the untreated value, suggesting a
reversible effect.
For additional controls, the effect of ASO on other
mediators of cartilage damage, antibodies to the
alpha5beta1 receptor, LPS and IL-1, were tested. Table I
shows that the antibody enhanced PG degradation, ASO
signficantly blocked the enhanced degradation and SO was
ineffective. LPS also enhanced PG degradation; however,
the activity was not blocked by ASO or by SO. As expected,
IL-1 enhanced PG degradation, but ASO and SO had no
effect on this activity. Thus, the ability of ASO to block
activity caused by antibodies to the alpha5beta1 receptor
confirms that the effect of the ASO on Fn-f mediated
activities does occur through this receptor. The inability of
ASO to block LPS activity confirms our other observations
that Fn-fs do not mediate activity through LPS. The inability
of ASO to block IL-1 activity suggests that under our
conditions and during the time frame of our experiments,
388 G. A. Homandberg et al.: Antisense blocks fibronectin fragmentsIL-1 activity is not mediated through generation of Fn-fs,
which can induce IL-1.ASO ALSO DECREASED THE EFFECTS OF THE FN-F ON
DECREASING THE PG CONTENT OF CULTURED CARTILAGE
Since PG degradation is only one marker of Fn-f-
mediated catabolism, the final PG content of the cultured
cartilage was also measured, as a marker of effects on
steady state levels of PG, which would also reflect possible
involvement of the alpha5 subunit in anabolism. Figure 8
shows that the oligos alone did not affect the PG content
and that the 29 kDa Fn-f significantly reduced the PG
content by 52%. Only ASO significantly reversed the Fn-f
activity and did so at concentrations as low as 10 nM. Thus,
the ASO blocked both Fn-f mediated PG catabolism and
the overall effects on PG content.0
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Our preliminary data suggested that the alpha5beta1
RGDS dependent Fn receptor integrin is at least partly
responsible for Fn-f activities. Although other alpha sub-
units have been detected on chondrocytes29, the
alpha5beta1 is the major Fn receptor30 and has been
shown to be involved in matrix interactions and proliferationof chondrocytes31. Antibodies to this receptor, as well as
RGDS peptides also block adhesion of chondrocytes to
Fn32. Further, this receptor is also involved in Fn-f mediated
induction of MMPs in synovial fibroblasts33. We had
observed that rabbit antihuman polyclonal antibodies to the
alpha5beta1 Fn receptor mimicked the activities of the Fn-f
(unpublished) and that peptides resembling the receptor-
binding sequence blocked the Fn-f activity26. Thus, the
focus of this work was on the alpha5 subunit.
Our objective here was to determine whether down-
regulation of the alpha5 protein with ASO would block the
action of the Fn-fs. It was assumed that down-regulation of
this subunit would decrease levels of the alpha5beta1
integrin. We focused on the alpha5 subunit, rather than
the beta1, because of the role of the alpha5 in dictating
specificity of the integrins. We chose to use an antisense
approach to implicate a role for this subunit, since there is
precedent for using ASO to probe integrin function. For
example, ASO to beta1 has been used to probe function in
osteosarcoma cells34 and to decrease focal contact forma-
tion on Fn and to alter cell morphology35. ASO to beta1 or
alpha subunits has been shown to decrease neural crest
cell attachment to laminin or Fn substrata36 and ASO to
alpha subunits has been shown to inhibit neural crest cell
adhesion to Fn and laminin37.
Our studies focused on studies of bovine explant cul-
tures, because the effects of the Fn-fs on these cultures
Osteoarthritis and Cartilage Vol. 10, No. 5 3890
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Effect of ASO on rates of PG degradation by other mediators
Anti-alpha5beta1 No. Oligo +ASO +SO
0.1 g/ml 1.46±0.11 1.05±0.21* 1.35±0.26
1 g/ml 2.32±0.17 0.91±0.19* 2.41±0.26
LPS
10 g/ml 2.76±0.14 2.92±0.37 3.05±0.56
IL-1
2 ng/ml 2.47±0.15 2.72±0.48 2.31±0.41
20 ng/ml 3.35±0.35 3.56±0.40 3.41±0.32
Bovine cartilage was cultured in DMEM and adjusted to oligo
free or 1 M oligo conditions. After 48 h, fresh media were added
which also included the test mediators. Aliquots of conditioned
media were then withdrawn at various times and assayed for PG
content. Rates of g PG/mg cartilage/day are shown without
correction for untreated control (no mediator, no oligo) rate which
was 1.09±0.11 (r2=0.91). The rate for Fn-f treatment was
3.95±0.4 (r2=0.92), which indicates this cartilage preparation was
susceptible to Fn-f damage. Rates for SO and ASO treatment
alone were 1.02±0.09 and 1.13±0.26, respectively. The rates and
r2 values were based on analysis of three culture wells for each of
the five time points (days 1, 3, 5, 7 and 9) or in this case, N=15.
The r2 values for all slopes varied from 0.85 to 0.97 with an
average of 0.90. *Indicates statistical significance at the level of
<0.0001 when compared to respective no oligo control data (left
column).have been more completely described by us than the
effects on monolayer cultures. We also used mostly serum-
free cultures because of a concern for interference byserum components, which we later verified. We studied two
homogeneous Fn-fs, the amino-terminal 29 kDa and
gelatin-binding 50 kDa Fn-fs, as well as a mixture, termed
140 kDa Fn-f, which contained all fragments carboxyl-
terminal to the 29 kDa and 50 kDa Fn-fs. This mixture also
contains the RGDS receptor-binding sequence.
The effects of phosphorthioate oligos on mRNA levels of
the alpha5 subunit were tested first. Phosphorthioate pro-
tection was chosen to improve stability and penetration
through membranes. Because of the possibility that the
backbone of the phosphorthioate oligo itself may have
secondary activities38–40, the ASO results were compared
to that of the SCO and SO, as controls, rather than to Oligo
minus experiments as controls. The analysis showed the
ASO decreased alpha5 mRNA and protein levels as com-
pared with SCO and SO in both types of culture systems
studied, cartilage explants and chondrocyte monolayer
cultures.
The effect of ASO on PG synthesis was tested in both
types of culture systems and shown to block the effect of all
three Fn-fs on PG synthesis. The ASO was effective as low
as 1 nM. The effect of the ASO on Fn-f mediated PG
synthesis was reversible and thus, non-cytotoxic, was also
dose dependent and required between 1 and 3 days for a
maximal effect on cartilage tissue. The SCO or SO had no
effect by themselves either on PG synthesis or in blocking
the effect of the Fn-fs. The ASO also reversed the ability of
the Fn-fs to suppress general protein synthesis, also sug-
gesting a non-cytotoxic effect, and showed a reversible and
a dose-dependent effect, which required between 1 and
2 days for maximal activity. In terms of PG degradation,
the ASO, SCO and SO, by themselves, did not cause PG
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Fig. 8. Effect of 1 M oligos on 29 kDa Fn-f mediated PG depletion of cartilage explants in serum-free cultures. Cartilage cultured as in Fig.
6 was assayed for total PG content, 7 days after addition of the 29 kDa Fn-f. Shown is PG content. Numbers in front of type of oligos refer
to M concentrations. P values of <0.05 or <0.01 are designated as * and **, respectively. Comparisons were made to Fn-f alone as control.degradation or block Fn-f mediated degradation. Only the
ASO decreased the ability of the Fn-fs to both enhance the
kinetics of PG degradation and to decrease the PG content
of cultured cartilage. We also found that antibodies to the
alpha5beta1 receptor enhanced PG degradation while the
ASO blocked this effect. This further confirms that our ASO
sequence affected levels of the alpha5beta1 receptor and
indirectly confirms the role of this receptor in Fn-f activities
since the ASO reduced both Fn-f and anti-receptor
mediated activities. Others have also demonstrated that
antibodies to the alpha5beta1 mimick activities of Fn-fs and
can also upregulate MMPs33. However, it should not
be assumed that the antibody alters signal transduction
similarly to the Fn-fs.
Our control experiments demonstrated several important
points. Polymixin B sulfate, a blocker of LPS activities, did
not block the Fn-fs activities, consistent with our obser-
vation that endotoxin levels in Fn-f solutions were insignifi-
cant. Further, ASO did not block the effect of LPS on PG
degradation. Therefore, the Fn-f effects are not mediated
through LPS contamination. We also found that ASO did
not block the effect of IL-1 on PG degradation. The
simplest interpretation is that IL-1 does not mediate its
activities by enhancing degradation of cartilage Fn to
generate Fn-f which would act on the alpha5beta1 receptor.
However, it is possible that generation of Fn-fs might
occur too late in the IL-1 treated culture to contribute to
the PG degradation. ASO might eventually decrease IL-1
mediated damage in much longer cultures than tested
here. Since such long-term cultures would requireadditional characterization of secondary effects of the ASO,
they were not included in this study.
The observation that a 5-day pre-incubation with ASO
was less effective than a 3-day pre-incubation may sug-
gest that down-regulation of one integrin may lead to
up-regulation of another that could bind Fn-fs. For example,
ligation of the alpha5beta1 receptor is required for internal-
ization of vitronectin by alphaVbeta341. Also, both the
alpha5beta1 and alpha4beta1 receptors are required for
MMP gene expression induced by Fn-fs in fibroblasts42.
Thus, while our data implicate the alpha5 as a target of the
Fn-fs, there may be other receptors that can either interact
directly or indirectly with the Fn-fs or that can regulate the
Fn-f activity by communicating with the alpha5 subunit.
The demonstration that all three Fn-fs may mediate their
activities through the alpha5-containing receptor is consist-
ent with other observations that show the amino-terminus
of Fn is also involved in Fn interaction with the cell
membrane. For example, amino-terminal Fn-fs and anti-
bodies to them inhibit pericellular matrix assembly43 and
block interaction of receptor with receptor antibodies44. The
amino-terminal 29 kDa segment is required for formation of
a Fn matrix and this segment binds only when the
alpha5beta1 integrin is present45. It has also been shown
that the amino-terminal region of Fn binds cells only when
both Fn and the Fn receptor are present. This has been
interpreted to suggest that the amino-terminal region is
required for binding to Fn fibrils43. Some of these observa-
tions have been reconciled into a model46 in which the
amino-terminal segment binds Fn fibrils, formed through
Osteoarthritis and Cartilage Vol. 10, No. 5 391domain-to-domain interactions47–49, which causes a con-
formational change that allows interaction of the cell-
binding region (contained within 140 kDa Fn-f) with the
receptor.
Based on the discussion above, it is possible that the
Fn-fs added to chondrocytes might interfere with binding of
native Fn to either the receptor or to fibrils or competitively
displace Fn and thus alter the composition and signaling
character of the pericellular matrix. The Fn-fs might do so
either by binding to the Fn receptor or very near it, or
instead, by binding to Fn or Fn fibrils in a self-assocation
mode and altering the way in which this Fn complex
regulates receptor activity. This could occur without displac-
ing Fn or fibrils. In such a revised model, Fn would be
required for Fn-f activity, similar to the requirement that Fn
be present for binding of the N-terminal domain to cells43.
Alternately, Fn-fs may bind to other non-Fn matrix compo-
nents near Fn receptors and indirectly alter signalling
without displacing Fn. It is also conceivable that Fn-fs could
bind to or near unoccupied Fn receptors and cause an
altered signal transduction pathway. Since in any of these
scenarios, the Fn-fs would indirectly mediate their effects
through the Fn receptor, our data cannot be used to confirm
any of these pathways.
It might be predicted that Fn-f mediated disruption or
modification of Fn interaction with a Fn receptor in chondro-
cytes would have diverse effects, based on other observa-
tions. For example, in the absence of attachment to Fn,
integrin alpha5beta1 expression activates a pathway lead-
ing to decreased cellular proliferation of HT29 colon carci-
noma cells while ligation of receptor with Fn reverses
this signal50. Further, disruption of binding of Fn to the
alpha5beta1 integrin stimulates cyclin dependent kinases
and DNA synthesis and activation of MAP kinases51.
Disruption of binding may also decrease Fn receptor con-
tent in the membrane. When attachment of substrate to the
alpha5beta1 integrins is blocked, the integrins become both
internalized and degraded52. Thus, the overall mechanism
for the action of the Fn-fs may be to destabilize Fn fibrils or
block Fn interaction with the Fn receptor.
We have shown by a chemical cross-linking approach
that all three Fn-fs and Fn bind close enough to the alpha5
subunit to be chemically crosslinked (Homandberg et al.,
submitted). The work reported here shows that this inter-
action might have functional significance since this subunit
is required for the Fn-fs to exert their effects on PG
synthesis suppression and MMP up-regulation. While we
cannot rule out the additional involvement of other recep-
tors, our work shows that the alpha5 subunit should be a
target for blocking the action of the Fn-fs. This may be
crucial for blocking cartilage degeneration in OA, because
of the likely physiologic relevance of Fn-fs in this disease.Acknowledgments
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